Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours
Open Access
- 1 June 2020
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 51 (12), 1247-1267
- https://doi.org/10.1111/apt.15765
Abstract
Background Neuroendocrine tumours (NETs) of the stomach and duodenum are rare, but are increasing in incidence. Optimal management of localised, low-grade gastric and duodenal NETs remains controversial. Aims To systematically review recent literature that has evaluated the management of localised low-grade gastric and duodenal NETs. Methods A systematic literature search was conducted. Articles were screened and eligible articles fully assessed. Additional articles were identified through the included articles' reference lists. Results Several relevant retrospective case series were identified, but there was considerable heterogeneity between studies and they reported a variety of parameters. Type I gastric NETs had an excellent prognosis and conservative management approaches such as endoscopic surveillance/resection were appropriate in most cases. Many type III gastric NETs were low grade and appeared to have a better prognosis than has previously been appreciated. Endoscopic rather than surgical resection was therefore effective in some patients who had small, low-grade tumours. Duodenal NETs were more heterogenous. Endoscopic resection was generally safe and effective in patients who had small, low-grade, nonfunctional, non-ampullary tumours. However, some patients, especially those with larger or ampullary duodenal NETs, required surgical resection. Conclusions Most type I gastric NETs behave indolently and surgical resection is only rarely indicated. Some type III gastric and duodenal NETs have a worse prognosis, but selected patients who have small, localised, nonfunctional, low-grade tumours are adequately and safely treated by endoscopic resection. Due to the complexity of this area, a multidisciplinary approach to management is strongly recommended.This publication has 68 references indexed in Scilit:
- Autoimmune atrophic gastritis—pathogenesis, pathology and managementNature Reviews Gastroenterology & Hepatology, 2013
- Management Strategy for Small Duodenal Carcinoid Tumors: Does Conservative Management with Close Follow-Up Represent an Alternative to Endoscopic Treatment?Digestion, 2013
- Gastric Neuroendocrine Tumors in Our Institutions According to the WHO 2010 ClassificationInternational Surgery, 2013
- Endoscopic submucosal dissection for foregut neuroendocrine tumors: An initial studyWorld Journal of Gastroenterology, 2012
- Clinical Impact of Endoscopic Submucosal Dissection for Gastric Neuroendocrine Tumors: A Retrospective Study from Mainland of ChinaThe Scientific World Journal, 2012
- Type I Gastric Carcinoids: A Prospective Study on Endoscopic Management and Recurrence RateNeuroendocrinology, 2011
- Clinicopathological evaluation of duodenal well-differentiated endocrine tumorsWorld Journal of Gastroenterology, 2010
- Review article: strategies to determine whether hypergastrinaemia is due to Zollinger–Ellison syndrome rather than a more common benign causeAlimentary Pharmacology & Therapeutics, 2009
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008
- Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumoursDigestive and Liver Disease, 2007